A novel role for TL1A/DR3 in protection against intestinal injury and infection

Journal of Immunology

Volumn 197, Issue 1, 2016, Pages 377-386

  Jia, Li Guo ^a   Bamias, Giorgos ^b   Arseneau, Kristen O ^a   Burkly, Linda C ^c   Wang, Eddy C Y ^d   Gruszka, Dennis ^a   Pizarro, Theresa T ^a   Cominelli, Fabio ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c BIOGEN   (United States)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; DEATH RECEPTOR 3; DEXTRAN SULFATE; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR LIKE CYTOKINE 1A; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; TNFRSF25 PROTEIN, MOUSE; TNFSF15 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD4+ CD25+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; FEMALE; IMMUNOPHENOTYPING; IMMUNOREGULATION; MOUSE; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SIGNAL TRANSDUCTION; TH17 CELL; UPREGULATION; ANIMAL; CELL CULTURE; GENETICS; HUMAN; IMMUNOLOGY; INTESTINE; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOLOGY; REGULATORY T LYMPHOCYTE; SCID MOUSE;

ANIMALS; CELLS, CULTURED; COLITIS; DEXTRAN SULFATE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTESTINES; MICE; MICE, KNOCKOUT; MICE, SCID; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84975231552     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502466     Document Type: Article

References (51)

1. Harrison, O. J., and K. J. Maloy. 2011. Innate immune activation in intestinal homeostasis. J. Innate Immun. 3: 585-593.
2. Bamias, G., D. Corridoni, T. T. Pizarro, and F. Cominelli. 2012. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 59: 451-459.
3. Bamias, G., M. R. Nyce, S. A. De La Rue, and F. Cominelli, American College of Physicians, American Physiological Society. 2005. New concepts in the pathophysiology of inflammatory bowel disease. Ann. Intern. Med. 143: 895-904.
4. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
5. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620.
6. Chinnaiyan, A. M., K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990-992.
7. Kitson, J., T. Raven, Y. P. Jiang, D. V. Goeddel, K. M. Giles, K. T. Pun, C. J. Grinham, R. Brown, and S. N. Farrow. 1996. A death-domain-containing receptor that mediates apoptosis. Nature 384: 372-375.
8. Bamias, G., M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli. 2006. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. USA 103: 8441-8446.
9. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S. Hong, J.W. Perry, S. F. Chen, J. X. Zhou, et al. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492.
10. Prehn, J. L., S. Mehdizadeh, C. J. Landers, X. Luo, S. C. Cha, P. Wei, and S. R. Targan. 2004. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-g, in mucosal inflammation. Clin. Immunol. 112: 66-77.
11. Prehn, J. L., L. S. Thomas, C. J. Landers, Q. T. Yu, K. S. Michelsen, and S. R. Targan. 2007. The T cell costimulator TL1A is induced by FcgR signaling in human monocytes and dendritic cells. J. Immunol. 178: 4033-4038.
12. Meylan, F., A. C. Richard, and R. M. Siegel. 2011. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol. Rev. 244: 188-196.
13. Bamias, G., L. G. Jia, and F. Cominelli. 2013. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation. Curr. Opin. Gastroenterol. 29: 597-602.
14. Schreiber, T. H., and E. R. Podack. 2013. Immunobiology of TNFSF15 and TNFRSF25. Immunol. Res. 57: 3-11.
15. Schreiber, T. H., D. Wolf, M. S. Tsai, J. Chirinos, V. V. Deyev, L. Gonzalez, T. R.Malek, R. B. Levy, and E. R. Podack. 2010. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 120: 3629-3640.
16. Zhang, J., X. Wang, H. Fahmi, S. Wojcik, J. Fikes, Y. Yu, J. Wu, and H. Luo. 2009. Role of TL1A in the pathogenesis of rheumatoid arthritis. J. Immunol. 183: 5350-5357.
17. Fang, L., B. Adkins, V. Deyev, and E. R. Podack. 2008. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205: 1037-1048.
18. Shih, D. Q., K. S. Michelsen, R. J. Barrett, E. Biener-Ramanujan, R. Gonsky, X. Zhang, and S. R. Targan. 2011. Insights into TL1A and IBD pathogenesis. Adv. Exp. Med. Biol. 691: 279-288.
19. Takedatsu, H., K. S. Michelsen, B. Wei, C. J. Landers, L. S. Thomas, D. Dhall, J. Braun, and S. R. Targan. 2008. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135: 552-567.
20. Meylan, F., Y. J. Song, I. Fuss, S. Villarreal, E. Kahle, I. J. Malm, K. Acharya, H. L. Ramos, L. Lo, M. M. Mentink-Kane, et al. 2011. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol. 4: 172-185.
21. Shih, D. Q., R. Barrett, X. Zhang, N. Yeager, H. W. Koon, P. Phaosawasdi, Y. Song, B. Ko, M. H. Wong, K. S. Michelsen, et al. 2011. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS One 6: e16090.
22. Taraban, V. Y., T. J. Slebioda, J. E. Willoughby, S. L. Buchan, S. James, B. Sheth, N. R. Smyth, G. J. Thomas, E. C. Wang, and A. Al-Shamkhani. 2011. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol. 4: 186-196.
23. Bamias, G., G. Kaltsa, S. I. Siakavellas, M. Gizis, G. Margantinis, E. Zampeli, I. Vafiadis-Zoumboulis, S. Michopoulos, G. L. Daikos, and S. D. Ladas. 2012. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease. Dig. Liver Dis. 44: 30-36.
24. Bamias, G., G. Kaltsa, S. I. Siakavellas, K. Papaxoinis, E. Zampeli, S. Michopoulos, I. Zouboulis-Vafiadis, and S. D. Ladas. 2010. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Clin. Immunol. 137: 242-249.
25. Thiébaut, R., S. Kotti, C. Jung, F. Merlin, J. F. Colombel, M. Lemann, S. Almer, C. Tysk, M. O'Morain, M. Gassull, et al. 2009. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am. J. Gastroenterol. 104: 384-391.
26. Yang, S. K., J. Lim, H. S. Chang, I. Lee, Y. Li, J. Liu, andK. Song. 2008. Association of TNFSF15 with Crohn's disease in Koreans. Am. J. Gastroenterol. 103: 1437-1442.
27. Barthel, M., S. Hapfelmeier, L. Quintanilla-Martínez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. Russmann, and W. D. Hardt. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71: 2839-2858.
28. Perse, M., and A. Cerar. 2012. Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012: 718617.
29. Dieleman, L. A., M. J. Palmen, H. Akol, E. Bloemena, A. S. Peña, S. G. Meuwissen, and E. P. Van Rees. 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114: 385-391.
30. Boehm, F., M. Martin, R. Kesselring, G. Schiechl, E. K. Geissler, H. J. Schlitt, and S. Fichtner-Feigl. 2012. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol. 12: 97.
31. Jones, G. W., J. S. Stumhofer, T. Foster, J. P. Twohig, P. Hertzog, N. Topley, A. S. Williams, C. A. Hunter, B. J. Jenkins, E. C. Wang, and S. A. Jones. 2011. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 25: 409-419.
32. Lopetuso, L. R., S. Chowdhry, and T. T. Pizarro. 2013. Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease. Front. Immunol. 4: 181.
33. Nenci, A., C. Becker, A. Wullaert, R. Gareus, G. van Loo, S. Danese, M. Huth, A. Nikolaev, C. Neufert, B. Madison, et al. 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557-561.
34. Mizoguchi, E., Y. Hachiya, M. Kawada, K. Nagatani, A. Ogawa, K. Sugimoto, A. Mizoguchi, and D. K. Podolsky. 2008. TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality. Gastroenterology 134: 470-480.
35. Naito, Y., T. Takagi, O. Handa, T. Ishikawa, S. Nakagawa, T. Yamaguchi, N. Yoshida, M. Minami, M. Kita, J. Imanishi, and T. Yoshikawa. 2003. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-A deficient mice. J. Gastroenterol. Hepatol. 18: 560-569.
36. Pagnini, C., R. Saeed, G. Bamias, K. O. Arseneau, T. T. Pizarro, and F. Cominelli. 2010. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc. Natl. Acad. Sci. USA 107: 454-459.
37. Jin, S., J. Chin, S. Seeber, J. Niewoehner, B. Weiser, N. Beaucamp, J. Woods, C. Murphy, A. Fanning, F. Shanahan, et al. 2013. TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFa, from CD3+CD161+ T cells to exacerbate gut inflammation. Mucosal Immunol. 6: 886-899.
38. Al-Lamki, R. S., J. Wang, A. M. Tolkovsky, J. A. Bradley, J. L. Griffin, S. Thiru, E. C. Wang, E. Bolton, W. Min, P. Moore, et al. 2008. TL1A both promotes and protects from renal inflammation and injury. J. Am. Soc. Nephrol. 19: 953-960.
39. Bamias, G., C. Martin, III, M. Marini, S. Hoang, M. Mishina, W. G. Ross, M. A. Sachedina, C. M. Friel, J. Mize, S. J. Bickston, et al. 2003. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171: 4868-4874.
40. Papadakis, K. A., J. L. Prehn, C. Landers, Q. Han, X. Luo, S. C. Cha, P. Wei, and S. R. Targan. 2004. TL1A synergizes with IL-12 and IL-18 to enhance IFN-g production in human T cells and NK cells. J. Immunol. 172: 7002-7007.
41. Twohig, J. P., M. Marsden, S. M. Cuff, J. R. Ferdinand, A. M. Gallimore, W. V. Perks, A. Al-Shamkhani, I. R. Humphreys, and E. C. Wang. 2012. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4+ and CD8+ T-cell immunity. FASEB J. 26: 3575-3586.
42. Ahn, Y. O., M. A. Weeres, M. L. Neulen, J. Choi, S. H. Kang, D. S. Heo, R. Bergerson, B. R. Blazar, J. S. Miller, and M. R. Verneris. 2015. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation. Eur. J. Immunol. 45: 2335-2342.
43. Holmkvist, P., K. Roepstorff, H. Uronen-Hansson, C. Sandén, S. Gudjonsson, O. Patschan, O. Grip, J. Marsal, A. Schmidtchen, L. Hornum, et al. 2015. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Ra and DR3, display innate lymphocyte functionality. Mucosal Immunol. 8: 545-558.
44. Buchan, S. L., V. Y. Taraban, T. J. Slebioda, S. James, A. F. Cunningham, and A. Al-Shamkhani. 2012. Death receptor 3 is essential for generating optimal protective CD4+ T-cell immunity against Salmonella. Eur. J. Immunol. 42: 580-588.
45. Weaver, C. T., and R. D. Hatton. 2009. Interplay between the TH17 and TReg cell lineages: A (co-)evolutionary perspective. Nat. Rev. Immunol. 9: 883-889.
46. Liao, W., J. X. Lin, L. Wang, P. Li, and W. J. Leonard. 2011. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 12: 551-559.
47. Pappu, B. P., A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al. 2008. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205: 1049-1062.
48. Ishimaru, N., A. Yamada, M. Kohashi, R. Arakaki, T. Takahashi, K. Izumi, and Y. Hayashi. 2008. Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+ regulatory T cell dysfunction. J. Immunol. 180: 6997-7008.
49. Eastaff-Leung, N., N. Mabarrack, A. Barbour, A. Cummins, and S. Barry. 2010. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol. 30: 80-89.
50. Khan, S. Q., M. S. Tsai, T. H. Schreiber, D. Wolf, V. V. Deyev, and E. R. Podack. 2013. Cloning, expression, and functional characterization of TL1A-Ig. J. Immunol. 190: 1540-1550.
51. Sandborn, W. J., J. F. Colombel, B. E. Sands, P. Rutgeerts, S. R. Targan, R. Panaccione, B. Bressler, K. Geboes, S. Schreiber, R. Aranda, et al. 2012. Abatacept for Crohn's disease and ulcerative colitis. Gastroenterology 143: 62-69.e4.